UNSPSC 51422001: Cosyntropin or tetracosactide

This classification denotes a diagnostic reagent, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 72YY86EA29. European Medicines Agency schedules Cosyntropin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10941MIG. Tetracosactide generally arises in the molecular formula C136H210N40O31S. The term 'tetracosactide' is a European Pharmacopoeia designation. TETRACOSACTIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51422001 Cosyntropin or tetracosactide is a Commodity code that in recent state and local procurement activity covers pharmaceutical products and drug-related systems procured to support public health and community health initiatives. The code shows a mismatch between its nominal pharmaceutical scope and the actual work being solicited: recent opportunities tagged to this code involve naloxone procurement and drug deactivation systems rather than cosyntropin itself. Issuing bodies include county governments and state health and human services agencies pursuing competitive acquisition of these products and related services to support emergency response, substance-abuse intervention, and pharmacy benefit management across multiple jurisdictions.

Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to its Community Health Building, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities and market intelligence on direct-to-manufacturer prescription programs and pharmacy benefit contracting models, with response due April 3, 2026. Geographic activity centers on Texas and Florida; the sparse recent-opportunity record and the categorical mismatch between the code's nominal scope and the naloxone procurement suggest limited current state and local contracting velocity under this code.